BNP Paribas Financial Markets
DRTS icon

BNP Paribas Financial Markets’s Alpha Tau Medical DRTS Stock Holding History

BNP Paribas Financial Markets’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.6K Buy
+7,360
New +$66.8K ﹤0.01% 4599

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM

BNP Paribas Financial Markets's DRTS Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 7,360 shares worth $92.6K. The stake represents ﹤0.01% of the portfolio and ranks #4599 among its holdings.

52 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • BNP Paribas Financial Markets held 7,360 shares of Alpha Tau Medical worth $92.6K as of Q2 2026.
  • Alpha Tau Medical was a new BNP Paribas Financial Markets position in Q2 2026.
  • Alpha Tau Medical made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4599 holding.
  • 52 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.